EUDA Health Holdings Ltd 6-K, filed Oct 13, 2026

EUDA Health Holdings Ltd (EUDA)

6-K 2026-10-13 For: 2026-10-13

Added on October 13, 2026

About this 6-K

EUDA Health Holdings Ltd filed this 6-K on October 13, 2026.

At its October 30, 2026 EGM, EUDA Health Holdings Limited asks shareholders to create Class A and Class B shares, with Class B carrying fifty (50) votes, giving Tan Meng Dong and 8i Capital Limited approximately 89.5% of voting power. AI summary

Search and read filings like this one from Claude or ChatGPT with the SEC filings MCP server →

99.1		Notice and Proxy Statement of the Company’s 2026 Extraordinary General Meeting of Shareholders.

99.2		Form of Proxy Card in connection with the Company’s 2026 Extraordinary General Meeting of Shareholders.

Dated: October 13, 2026

	EUDA Health Holdings Limited

	By:	/s/ Alfred Lim
	Name:	Alfred Lim
	Title:	Chief Executive Officer

By:	/s/ Alfred Lim
Name:	Alfred Lim
Title	Executive Director

	By Order of the Board of Directors
Dated: October 13, 2026	/s/ Alfred Lim
	Alfred Lim
	Executive Director

interpretation		1
1.	Definitions	1
SHARES		5
2.	Power to Issue Shares	5
3.	Power of the Company to Purchase its Shares	5
4.	Treatment of Purchased, Redeemed or Acquired Shares	5
5.	Treasury Shares	5
6.	Consideration	6
7.	Forfeiture of Shares	6
8.	Share Certificates	7
9.	Fractional Shares	7
REGISTRATION OF SHARES		7
10.	Register of Members	7
11.	Registered Holder Absolute Owner	7
12.	Transfer of Registered Shares	8
13.	Transmission of Registered Shares	8
ALTERATION OF SHARES
14.	Power to Alter Shares	9
15.	Restrictions on the Division of Shares	9
DISTRIBUTIONS		9
16.	Distributions	9
17.	Power to Set Aside Profits	10
18.	Unauthorised Distributions	10
19.	Distributions to Joint Holders of Shares	10
MEETINGS OF MEMBERS		10
20.	General Meetings	10
21.	Location	10
22.	Requisitioned General Meetings	10
23.	Notice	11
24.	Giving Notice	11
25.	Service of Notice	11
26.	Participating in Meetings by Telephone	12
27.	Quorum at General Meetings	12
28.	Chairman to Preside	12
29.	Voting on Resolutions	13
30.	Power to Demand a Vote on a Poll	13
31.	Voting by Joint Holders of Shares	13
32.	Instrument of Proxy	13
33.	Representation of Members	14
34.	Adjournment of General Meetings	14
35.	Business at Adjourned Meetings	14
36.	Directors Attendance at General Meetings	14

DIRECTORS AND OFFICERS		14
37.	Election of Directors	14
38.	Number of Directors	15
39.	Term of Office of Directors	15
40.	Alternate and Reserve Directors	15
41.	Removal of Directors	16
42.	Vacancy in the Office of Director	16
43.	Remuneration of Directors	16
44.	Resignation of directors	16
45.	Directors to Manage Business	16
46.	Committees of Directors	17
47.	Officers and Agents	18
48.	Removal of Officers and Agents	19
49.	Duties of Officers	19
50.	Remuneration of Officers	19
51.	Standard of Care	19
52.	Conflicts of Interest	20
53.	Indemnification and Exculpation	20
MEETINGS OF THE BOARD OF DIRECTORS		22
54.	Board Meetings	22
55.	Notice of Board Meetings	22
56.	Participation in Meetings by Telephone	22
57.	Quorum at Board Meetings	22
58.	Board to Continue in the Event of Vacancy	22
59.	Chairman to Preside	22
60.	Powers of Sole Director	22
61.	Proceedings if One Director	23
CORPORATE RECORDS		23
62.	Documents to be Kept	23
63.	Form and Use of Seal	24
ACCOUNTS		24
64.	Books of Account	24
65.	Form of Records	24
66.	Financial Statements	24
67.	Distribution of Accounts	24
AUDITS		25
68.	Audit	25
69.	Appointment of Auditor	25
70.	Remuneration of Auditor	25
71.	Duties of Auditor	25
72.	Access to Records	25
73.	Auditor Entitled to Notice	26
VOLUNTARY LIQUIDATION		26
74.	Liquidation	26
FUNDAMENTAL CHANGES		26
75.	Changes	26
76.	Continuation under Foreign Law	26

“Act”		BVI Business Companies Act, as from time to time amended or restated;

“Affiliates”		as defined in Rule 501(b) of Regulation D under the Securities Act;

“Articles”		these Articles of Association as originally registered or as from time to time amended or restated;

“Audit Committee”		the audit committee of the Company formed by the Board pursuant to Article 46.6, or any successor audit committee;

“Auditor”		the independent auditor of the Company which shall be an internationally recognized firm of independent accountants;

“Board” or “Director(s)”		the board of directors of the Company or the directors present at a meeting of directors of the Company at which a quorum is present;

“Class A Ordinary Share”		a class A ordinary share with no par value in the Company having the rights set out in the Memorandum;

“Class B Ordinary Share”		a class B ordinary share with no par value in the Company having the rights set out in the Memorandum;

“Company”		EUDA Health Holdings Limited;

“control”		means the possession, directly or indirectly, of the power to direct or cause the direction of the management policies of a person, whether through the ownership of voting securities, by contract or credit arrangement, as trustee or executor, or otherwise, and the terms “controlled by” and “under common control with” shall be construed as such;

“Designated Stock Exchange”	the stock exchange in the United States on which any shares of the Company (or depositary receipts therefor) are listed for trading;

“Distribution”	(a)	the direct or indirect transfer of an asset, other than the Company’s own shares, to or for the benefit of a Member; or

	(b)	the incurring of a debt to or for the benefit of a Member;

	in relation to shares held by a Member and whether by means of the purchase of an asset, the purchase, redemption or other acquisition of shares, a transfer of indebtedness or otherwise, and includes a dividend;

“Electronic Communication”	a communication sent by electronic means, including electronic posting to the Company’s website, transmission to any number, address or internet website (including the website of the SEC) or other electronic delivery methods as otherwise decided and approved by the Directors;

“electronic meeting”	a general meeting held and conducted wholly and exclusively by virtual attendance and participation by Members and/or proxies by means of electronic facilities;

“Exchange Act”	the U.S. Securities Exchange Act of 1934, as amended;

“Member”	a person whose name is entered in the register of members as the holder of one or more shares, or fractional shares, in the Company;

“Memorandum”	the amended and restated Memorandum of Association of the Company as originally registered or as from time to time amended or restated;

“Ordinary Shares”	the Class A Ordinary Shares and the Class B Ordinary Shares collectively;

“Resolution of Directors”	(a)	a resolution approved at a duly constituted meeting of directors or of a committee of directors of the Company by the affirmative vote of a simple majority of the directors present who voted and did not abstain; or

	(b)	subject to article 41.1, a resolution consented to in writing by all of the directors or of all the members of the committee, as the case may be;

“Resolution of Members”	(a)	a resolution approved at a duly constituted meeting of Members by the affirmative vote of a simple majority of the votes of those Members entitled to vote and voting on the resolution; or

	(b)	subject to article 41.1, a resolution consented to in writing by a majority of in excess of 50 percent of the votes of those Members entitled to vote and voting on the resolution;

“Seal”	the common seal of the Company;

“SEC”	the United States Securities and Exchange Commission;

“Secretary”	the person appointed to perform any or all of the duties of secretary of the Company and includes any deputy or assistant secretary and any person appointed by the Board to perform any of the duties of the Secretary;

“Securities Act”	the U.S. Securities Act 1933, as amended;

“Statutes”	the Act, the Exchange Act, the Securities Act and every other law of the Legislature of the British Virgin Islands or the United States of America for the time being in force applying to or affecting the Company, the Memorandum and/or these Articles; and

“Treasury Share”	a share of the Company that was previously issued but was repurchased, redeemed or otherwise acquired by the Company and not cancelled.

(2) To approve, subject to the approval by the shareholders of the Company of the Change in Authorised Shares and Re-classification, the amendment of the existing memorandum and articles of association of the Company, and the approval and adoption of the amended and restated memorandum and articles of association attached to the accompanying Proxy Statement as Exhibit A (the “Amended M&As”), in substitution for, and to the exclusion of, all the existing memorandum and articles of association.*	FOR ☐	AGAINST ☐	ABSTAIN ☐

(3) To approve the adjournment of the EGM to a later date or dates or sine die, if necessary or desirable, at the discretion of the directors, to permit further solicitation and vote of proxies if, at the time of the EGM, there are not sufficient votes for, or otherwise in connection with, the approval of the foregoing proposals.*	FOR ☐	AGAINST ☐	ABSTAIN ☐

	Date: , 2026
______________________________________________________________	Signature
______________________________________________________________	Signature (if held jointly)